55
posted ago by sleepydude ago by sleepydude +55 / -0

It really sounds like how Ivermectin, HCQ, and others are purported to act.

YKYRYL carries the dominant binding epitope and binds to ACE2 with KD = 46 μM. The binding mode was further characterized by saturation transfer difference (STD) NMR spectroscopy and molecular dynamic simulations. Based on this information the peptide can be used as lead structure to design potential entry inhibitors against SARS-CoV and related viruses.

2012 - https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114193/

Hexapeptide YKYRYL specifically inhibits SARS infection in cells.

Ding ding, sounds like they skipped past a proven treatment, in their own NIH study, in order to push the "vaccines" instead. Add it to the list of proofs they never intended to do anything but manufacture these Frankenstein's monster, chop-shop "vaccines."

2020 -

https://www.cell.com/biophysj/fulltext/S0006-3495(20)30670-6

https://www.biorxiv.org/content/10.1101/2020.06.03.132506v1.full

Using MD simulations, we investigate the assembly process of a Coronavirus Spike protein fragment, the hexapeptide YKYRYL on the ACE2 receptor and its inhibitzory effect on the aggregation and activation of the CoV-2 spike receptor protein at the same receptor protein.